On Friday, Following U.S. Stocks were among the “Top Gainers”:Anacor Pharmaceuticals (NASDAQ:ANAC), Ampio Pharmaceuticals (NYSEMKT:AMPE), El Pollo LoCo Holdings (NASDAQ:LOCO), Violin Memory (NYSE:VMEM)
Anacor Pharmaceuticals Inc (NASDAQ:ANAC), with shares jumped 14.72%, settled at $55.66, hitting new 52-week high of $56.98.
Ampio Pharmaceuticals Inc (NYSEMKT:AMPE), with shares inclined 14.33%, closed at $7.98.
El Pollo LoCo Holdings Inc (NASDAQ:LOCO), with shares climbed 12.92%, and closed at $27.10.
Violin Memory Inc (NYSE:VMEM), surged 11.71%, and closed at $3.53
Latest NEWS regarding these Stocks are depicted underneath:
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)
Anacor Pharmaceuticals, Inc. (ANAC), declared that the following abstracts have been accepted for presentation at the forthcoming 73rd Annual Meeting of the American Academy of Dermatology to be held in San Francisco, California March 20 to 24, 2015:
- AN2728, an investigational non-steroidal topical PDE-4 inhibitor for the potential treatment of mild-to-moderate atopic dermatitis in children and adults
- “Maximal Use Systemic Exposure (MUSE) Study Evaluating AN2728, A Novel Boron-Based Small Molecule, for the Treatment of Pediatric and Adolescent Subjects with Mild-to-Moderate Atopic Dermatitis” to be presented by Zoe Draelos, M.D. on Friday, March 20 at 4:30 P.D.T.
- “AN2728, A New Boron-Based Topical Anti-Inflammatory Agent, Inhibits Phosphodiesterase 4” to be presented by Lee Zane, M.D. on Saturday, March 21 at 9:25 a.m. P.D.T.
- KERYDIN (tavaborole) topical solution, 5%
- “In Vitro Study Demonstrating Nail Penetration of Tavaborole Topical Solution, 5% Through Multiple Layers of Nail Polish” to be presented by Tracey Vlahovic, DPM, on Sunday, March 22 at 11:35 a.m. P.D.T.
Anacor is a biopharmaceutical corporation focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor’s first approved drug, KERYDIN® (tavaborole) topical solution, 5%, is an oxaborole antifungal approved by the U.S.
Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE)
Formerly on February 25, Ampio Pharmaceuticals, Inc. (AMPE), declared results of the double-blind, multiple injection, vehicle controlled STRUT study (N=40) at 20 weeks.
The forty patient randomized (1:1) phase of the STRUT study was conducted to assure that multiple injections of Ampion™ were safe and effective. Each patient received three 4 mL intra-articular injections of Ampion™ or saline at baseline, 2 weeks and 4 weeks. There were no drug related serious adverse events stated during the 20 weeks of this trial; the top-line results are as follows:
- WOMAC A: The primary endpoint that is required for FDA approval, WOMAC A pain score, improved by 64% from baseline to 20 weeks. Ampion™ improved by -1.41 (0.81) contrast to saline vehicle control which improved by -0.85 (0.64), p=0.0231.
- Responder Rate: Responder rate is defined as a change of at least 1 point in the WOMAC A pain subscale. Responder rate for Ampion™ was 79% contrast to 47% of saline patients,p=0.0451.
Data for the larger, multi-site STRIDE study (similar design to STRUT study) is predictable in second quarter 2015.
Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical corporation, develops therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the accessible phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.
El Pollo Loco Holdings, Inc. (NASDAQ:LOCO)
El Pollo Loco Holdings, Inc. (LOCO), declared financial results for the 14-week and 53-week periods ended December 31, 2014.
Steve Sather, President and Chief Executive Officer of El Pollo Loco Holdings, Inc., stated, “We are happy to have closed out fiscal 2014 with another strong quarter of sales and earnings growth. Our system-wide comparable restaurant sales growth of 7.6% marked our 14th successive quarter of positive comparable restaurant sales growth, as our unique ‘QSR-plus’ positioning, compelling value proposition, and broad menu offerings anchored by our signature fire-grilled chicken, continue to resonate with customers.”
Sather added, “As we look ahead to 2015, we’re excited about the opportunity to expand in both new and existing markets, bringing our fresh, hand-crafted Mexican inspired cuisine to customers across the country. Our initial expansion into Texas has gone extremely well and we expect to open 27 new El Pollo Loco restaurants in 2015, counting an additional six to eight restaurants in the Houston area. We believe that our differentiated ‘faster fast casual’ concept and strong operations position us well for sustainable long term growth and further value creation on behalf of our shareholders.”
El Pollo Loco Holdings, Inc., through its partner, El Pollo Loco, Inc., develops, franchises, licenses, and operates quick-service restaurants under the El Pollo Loco name in the United States.
Violin Memory, Inc. (NYSE:VMEM)
Violin Memory, Inc. (VMEM), a global pioneer of award-winning flash storage platform solutions for primary storage and active workloads, declared the launch of its Global Partner Program and a new easy-to-use online portal. Following the launch of the Violin Flash Storage Platform, the expanded Violin Global Partner Program establishes new incentives and business models that will enable partners to achieve success through simplified partner programs, more predictable performance rewards, and innovative tools to deliver consistency in partner engagement.
“The Violin mantra is ‘partner first,’” said Jeff Nollette, global vice president, Channel Sales. “We treat our channel partners as a natural extension of our salesforce, providing the same level of support and enablement. Repeatable and sustainable business will drive our partners and their customers to new levels in IT agility and performance while delivering the fastest ROI and lowest TCO, and we’re excited to work with our partners to expand mutual business and success.”
Violin Memory, Inc. develops and supplies memory-based storage systems to bring storage performance in line with high-speed applications, servers, and networks worldwide. Violin’s All Flash optimized solutions accelerate breakthrough CAPEX and OPEX savings for building the next generation data center. Violin’s Flash Fabric Architecture™ (FFA) speeds data delivery with chip-to-chassis performance optimization that achieves lower consistent latency and cost per transaction for Cloud, Enterprise and Virtualized mission-critical applications.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
